We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Senti Biosciences, Inc. has announced several key developments. The company secured stockholder approval for the amendment and restatement of its 2022 Equity Incentive Plan, adding 4,300,000 ...

On March 6, Senti Biosciences, Inc. (NASDAQ:SNTI), a company specializing in biological products with a market capitalization of $17.6 million, received stockholder approval for key proposals ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Senti Biosciences, Inc. is a biotechnology company. It engages in the business of developing next-generation cell and gene therapies engineered with a gene circuit platform technology to fight ...